Oculis Holding AG (OCS) Non-Current Debt (2021 - 2024)
Quarterly Non-Current Debt changed N/A to $433067.9 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $433067.9 through Mar 2024, changed N/A year-over-year, with the annual reading at $426140.0 for FY2023, 99.66% down from the prior year.
Oculis Holding AG's Non-Current Debt history spans 4 years, with the latest figure at $433067.9 for Q1 2024.
- Non-Current Debt came in at $433067.9 for Q1 2024, up from $426140.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $127.1 million in Q4 2022 to a low of $426140.0 in Q4 2023.
- The 4-year median for Non-Current Debt is $433067.9 (2024), against an average of $50.3 million.
- Year-over-year, Non-Current Debt rose 3.26% in 2022 and then crashed 99.66% in 2023.
- Oculis Holding AG's Non-Current Debt stood at $123.1 million in 2021, then rose by 3.26% to $127.1 million in 2022, then plummeted by 99.66% to $426140.0 in 2023, then grew by 1.63% to $433067.9 in 2024.
- Per Business Quant, the three most recent readings for OCS's Non-Current Debt are $433067.9 (Q1 2024), $426140.0 (Q4 2023), and $426821.5 (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 105.94 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.99 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 433,067.91 |
| Mar 31, 2024 | 433,067.91 |
| Dec 31, 2023 | 426,139.99 |
| Dec 31, 2023 | 426,139.99 |
| Sep 30, 2023 | 426,821.52 |
| Sep 30, 2023 | 426,821.52 |
| Dec 31, 2022 | 127.10 Mn |
| Dec 31, 2022 | 127.10 Mn |
| Dec 31, 2021 | 123.09 Mn |
| Dec 31, 2021 | 123.09 Mn |